Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mina Li

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Applied Optics|March 4, 2024
UV communication cooperative formation UAV alliance capture algorithmTaifei Zhao, Mina Li, Yi Zhao, et al.
BMC Endocrine Disorders|March 4, 2024
Association of serum asprosin with metabolic dysfunction-associated fatty liver disease in older adult type 2 diabetic patients: a cross-sectional studyJunfang Cui, Yunfeng Liu, Mina Li, et al.
Frontiers in Endocrinology|April 29, 2026
New findings in diabetic kidney disease: correlation and enhanced combined diagnostic value of sclerostin and 25(OH)VDChunfan Niu, Jianhong Yin, Mina Li, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|June 27, 2022
Association Between Serum Asprosin and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus in the Community: A Cross-Sectional StudyLinxin Xu, Junfang Cui, Mina Li, et al.
Journal of Diabetes Investigation|September 14, 2024
Association analysis between serum asprosin and metabolic characteristics, Complications in type 2 diabetic patients with different durationsLijing Ma, Zhengqian Wang, Li Sun, et al.
Frontiers in Endocrinology|August 15, 2024
The relationship between 25-hydroxy vitamin D and serum asprosin in patients with type 2 diabetes in the communityJunfang Cui, Zhengqian Wang, Jianhong Yin, et al.
International Journal of General Medicine|October 21, 2025
Henagliflozin Increases Serum and Salivary Levels of High-Molecular-Weight Adiponectin in Patients with Type 2 Diabetes in the CommunityLinxin Xu, Chunfan Niu, Yun Liu, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Applied Optics|March 4, 2024
UV communication cooperative formation UAV alliance capture algorithmTaifei Zhao, Mina Li, Yi Zhao, et al.
BMC Endocrine Disorders|March 4, 2024
Association of serum asprosin with metabolic dysfunction-associated fatty liver disease in older adult type 2 diabetic patients: a cross-sectional studyJunfang Cui, Yunfeng Liu, Mina Li, et al.
Frontiers in Endocrinology|April 29, 2026
New findings in diabetic kidney disease: correlation and enhanced combined diagnostic value of sclerostin and 25(OH)VDChunfan Niu, Jianhong Yin, Mina Li, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|June 27, 2022
Association Between Serum Asprosin and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus in the Community: A Cross-Sectional StudyLinxin Xu, Junfang Cui, Mina Li, et al.
Journal of Diabetes Investigation|September 14, 2024
Association analysis between serum asprosin and metabolic characteristics, Complications in type 2 diabetic patients with different durationsLijing Ma, Zhengqian Wang, Li Sun, et al.
Frontiers in Endocrinology|August 15, 2024
The relationship between 25-hydroxy vitamin D and serum asprosin in patients with type 2 diabetes in the communityJunfang Cui, Zhengqian Wang, Jianhong Yin, et al.
International Journal of General Medicine|October 21, 2025
Henagliflozin Increases Serum and Salivary Levels of High-Molecular-Weight Adiponectin in Patients with Type 2 Diabetes in the CommunityLinxin Xu, Chunfan Niu, Yun Liu, et al.
Pageof 1